Researchers at Nara Medical University in Kashikara, Japan, have launched what many are calling a “groundbreaking” clinical trial to develop universal artificial blood — enabling transfusions for patients of any blood type.
Read More Japan: Scientists launch clinical trials to ‘revolutionize medicine’ with universal artificial blood
Pfizer announced it is ending its development of its experimental oral GLP-1 drug to treat obesity, the company said on Monday, after a patient in a trial suffered a liver injury potentially caused by the experimental drug known as danuglipron.
Read More Pfizer Pulls Plug On Weight Loss Pill Amid Liver Damage Fears
FDA inspectors uncover quality control issues at Neuralink’s animal research facility.
Read More Exclusive: Musk’s Neuralink brain implant company cited by FDA over animal lab issues
Thousands volunteer for Elon Musk’s Neuralink microchip brain implant study.
Read More Thousands Express Interest In Volunteering To Receive Musk’s Neuralink Microchip